POLYPID LTD has a total of 79 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, China and Australia. Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are ROYER BIOMEDICAL INC, HEMOTEQ GMBH and ARCH BIOSURGERY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | China | 9 | |
#3 | Australia | 7 | |
#4 | Canada | 7 | |
#5 | EPO (European Patent Office) | 7 | |
#6 | WIPO (World Intellectual Property Organization) | 7 | |
#7 | Israel | 5 | |
#8 | Singapore | 4 | |
#9 | Brazil | 3 | |
#10 | Mexico | 3 | |
#11 | Philippines | 3 | |
#12 | Hong Kong | 2 | |
#13 | India | 2 | |
#14 | Japan | 2 | |
#15 | Republic of Korea | 2 | |
#16 | South Africa | 2 | |
#17 | EAPO (Eurasian Patent Organization) | 1 | |
#18 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology | |
#4 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Object sterilising | |
#4 | Implantable devices | |
#5 | Microorganisms | |
#6 | Macromolecular compounds compositions |
# | Name | Total Patents |
---|---|---|
#1 | Emanuel Noam | 68 |
#2 | Barak Shlomo | 13 |
#3 | Neuman Moshe | 13 |
#4 | Noam Emanuel | 10 |
#5 | Rosenfeld Yosef | 6 |
#6 | Shlomo Barak | 3 |
#7 | Moshe Neuman | 3 |
#8 | Yosef Rosenfeld | 1 |
Publication | Filing date | Title |
---|---|---|
CN107072885A | Method for treating peri-implantitiss | |
SG11201702469TA | Compositions and methods for the treatment and prophylaxis of surgical site infections | |
IL229721D0 | Matrix compositions for controlled release of peptide and polypeptide molecules | |
WO2014020610A1 | Compositions and methods for the treatment of bone voids and open fractures | |
WO2013014677A1 | Matrix compositions for controlled release of peptide and polypeptide molecules | |
IL220725D0 | Sustained-release nucleic acid matrix compositions | |
AU2011208374A1 | Sustained-release nucleic acid matrix compositions | |
CN102470105A | Sustained-release drug carrier composition | |
AU2009272280A1 | Sustained-release drug carrier composition |